Larry Goldstein to Cholesterol, LDL
This is a "connection" page, showing publications Larry Goldstein has written about Cholesterol, LDL.
Connection Strength
1.694
-
Lipids in high-risk patients presenting with ischemic stroke or transient ischemic attack: are we missing the target? Stroke. 2014 Nov; 45(11):3180-1.
Score: 0.456
-
The complex relationship between cholesterol and brain hemorrhage. Circulation. 2009 Apr 28; 119(16):2131-3.
Score: 0.313
-
Low LDL cholesterol, statins, and brain hemorrhage: should we worry? Neurology. 2007 Mar 06; 68(10):719-20.
Score: 0.269
-
Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2023 10; 43(10):e404-e442.
Score: 0.212
-
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun; 204(2):515-20.
Score: 0.075
-
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2008 Jun 10; 70(24 Pt 2):2364-70.
Score: 0.071
-
Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 Dec; 38(12):3198-204.
Score: 0.070
-
Statins for stroke prevention. Curr Atheroscler Rep. 2007 Oct; 9(4):305-11.
Score: 0.070
-
Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. J Am Coll Cardiol. 2020 08 18; 76(7):886-888.
Score: 0.043
-
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. J Am Coll Cardiol. 2020 05 05; 75(17):2110-2118.
Score: 0.042
-
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009 Jul; 40(7):2486-92.
Score: 0.020
-
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 Dec; 39(12):3297-302.
Score: 0.019
-
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology. 2009 Feb 24; 72(8):688-94.
Score: 0.019
-
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 08 10; 355(6):549-59.
Score: 0.016